Daiichi Sankyo Espha Likely to Roll Out Urief, Iressa Authorized Generics: December Listing

Daiichi Sankyo Espha continues to fuel its authorized generic (AG) business with new portfolios as it is expected to launch AG versions of two brands upon the next generic listing in December: Kissei Pharmaceutical’s dysuria treatment Urief (silodosin) and AstraZeneca’s...read more